Canada markets closed

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.17-0.58 (-2.09%)
At close: 04:00PM EDT
27.17 0.00 (0.00%)
After hours: 05:27PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.95B
Enterprise Value 3.26B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.81
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -12.85

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 354.20%
S&P500 52-Week Change 322.36%
52 Week High 345.58
52 Week Low 316.58
50-Day Moving Average 332.21
200-Day Moving Average 332.15

Share Statistics

Avg Vol (3 month) 31.17M
Avg Vol (10 day) 31.16M
Shares Outstanding 5145.29M
Implied Shares Outstanding 6145.29M
Float 864.28M
% Held by Insiders 155.53%
% Held by Institutions 147.60%
Shares Short (Apr 15, 2024) 48.51M
Short Ratio (Apr 15, 2024) 47.22
Short % of Float (Apr 15, 2024) 412.17%
Short % of Shares Outstanding (Apr 15, 2024) 45.86%
Shares Short (prior month Mar 15, 2024) 49.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.15%
Return on Equity (ttm)-44.51%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -253.37M
Net Income Avi to Common (ttm)-243.45M
Diluted EPS (ttm)-1.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)690.94M
Total Cash Per Share (mrq)4.76
Total Debt (mrq)306k
Total Debt/Equity (mrq)0.05%
Current Ratio (mrq)22.14
Book Value Per Share (mrq)4.68

Cash Flow Statement

Operating Cash Flow (ttm)-210.32M
Levered Free Cash Flow (ttm)-125.81M